HSHerrick J. Siegel

Herrick J. Siegel

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Herrick J. Siegel has a total of 28 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

    • 1 January 2015
      • Vol. 44  (1) , E1-E10

    Assessing the reading level of online sarcoma patient education materials.

    by Shaan S Patel, Evan D Sheppard, Herrick J Siegel, Brent A Ponce

    Cancer patients rely on patient education materials (PEMs) to gather information regarding their disease. Patients who are better informed about their illness have better health outcomes. The National Institutes of Health (NIH) recommends that PEMs be written at a sixth- to seventh-grade reading level. The purpose of this study was to evaluate the readability of online PEMs of bone and soft-tissue sarcomas and related conditions. We identified relevant online PEMs from the following websites: American Academy of Orthopaedic Surgeons, academic training centers, sarcoma specialists, Google search hits, Bonetumor.org, Sarcoma Alliance, Sarcoma Foundation of America, and Medscape. We used 10 different readability instruments to evaluate the reading level of each website's PEMs. In assessing 72 websites and 774 articles, we found that none of the websites had a mean readability score at or below 7 (seventh grade). Collectively, all websites had a mean readability score of 11.4, and the range of scores was grade level 8.9 to 15.5. None of the PEMs in this study of bone and soft-tissue sarcomas and related conditions met the NIH recommendation for PEM reading levels. Concerted efforts to improve the reading level of orthopedic oncologic PEMs are necessary.

  • Intracranial Meningeal Hemangiopericytoma Metastatic to the Scapula

    by Herrick J. Siegel, Robert Lopez-Ben, J. Hunter Sutton, Gene P. Siegal


  • Limb Preservation in Patients with Bone and Soft Tissue Tumors

    by Herrick J. Siegel

    Interview Herrick J. Siegel, MD Dr Siegel is from the Section of Orthopedic Oncology, University of Alabama at Birmingham, Orthopedics Specialties, Birmingham, Alabama. Dr Siegel has no relevant financial relationships to disclose. Correspondence should be addressed to: Herrick J. Siegel, MD, Orthopedic Oncology, UAB Orthopedics Specialties Bldg, 1313 13th St S, Birmingham, AL, 35205 (herrick.siegel@ortho.uab.edu). Advancements in imaging modalities have contributed dramatically to our ability to resect tumors while preserving essential neurovascular structures. Magnetic resonance imaging and angiography have provided precise detail of the anatomic boundaries of the tumor, as well as an accurate tool for surveillance of the resected tumor bed. Modern oncologic prosthetic devices have improved dramatically over the past decade. Modularity and more user friendly instrumentation have attracted many surgeons to incorporate these implants into complex adult reconstruction procedures. Adjuvant treatment, including radiation and chemotherapy, may be used effectively for local control. Presurgical treatment of both bone and soft tissue sarcomas often reduce tumor volume and allow for a wider surgical margin while preserving vital structures. Preoperative chemotherapy for Ewing sarcoma and osteosarcoma is particularly helpful because it provides information after resection regarding the tumor’s response to treatment. Greater than 95% tumor necrosis indicates a good response and has a more favorable prognosis. The success of chemotherapy in these 2 bone sarcomas has made a significant impact on our ability to perform limb salvage. Appropriate biopsy techniques have continued to be emphasized in the orthopedic literature. Longitudinal incisions, staying within a solitary compartment, and avoiding exposure of major neurovascular structures is crucial. Large studies have evaluated local recurrence; disease-free survival and survival outcome have not shown a significant difference between limb salvage and amputation. Amputation may be a better option than limb salvage if, following tumor resection, the function of the limb would be severely limited. This may occur following resections of large tumors involving the brachial plexus or a combination of the sciatic and femoral nerves. A painful, functionless limb is considered much worse than an amputated limb. Patients with extensive comorbidities that would not tolerate a large resection and reconstruction would be better served with an amputation. The length of surgery, blood loss, the incidence of infection, and in many cases, the postoperative recovery time, decreases with amputation. Amputation is often necessary to obtain a clear margin with sarcomas involving the hands and feet. Extremity prostheses continue to improve and are a viable option for a patient who will benefit little functionally from limb salvage or who has comorbidities placing the patient in jeopardy from a prolonged procedure and rehabilitation. Surgeon preference and experience plays a large role in the selection of which reconstruction will be performed. There are a wide range of reconstructive options for soft tissue and bone sarcomas. Bone sarcomas often require replacement of the adjacent joint. Modular oncologic replacement systems are commonly used. Proximal and distal femur replacements are the most common regions for modular oncologic prosthetic reconstruction. The allograft prosthetic composite is a popular reconstruction for proximal tibia reconstructions. It has the advantage of patella tendon attachment to the allograft with the enhanced stability afforded by a rotating hinge knee. Additionally, cadaver allograft alone or in combination with a joint replacement may also be considered. Intercalary allografts may be used for resections involving the diaphysis without joint involvement. Cadaver grafts may be used in combination with vascularized grafts. The vascularized fibula has been used successfully in many parts of the body to supplement other cadaver grafts, or alone. Soft tissue, nerves, and vessels are the limiting factors for adequate limb preservation. The bone can be reconstructed with cadaver bone and/or an oncologic prosthesis. The soft tissues need to be mobilized either from a local uninvolved region or through vascularized transfer. Potential complications should be anticipated and appropriate steps taken at the discretion of the surgical team. The barriers for limb preservation often are avoided by the establishment of a highly trained and skilled surgical team. This would consist of an orthopedic oncologist, vascular surgeon, plastic surgeon, and general surgical oncologist. Potential causes of morbidity include infection, pain and extensive rehabilitation. Blood loss and operative time is often significantly increased in general in comparison to amputation; and this may be a cause for concern depending on the age and comorbidities of the patient. Wound complications, allograft non-union and/or fracture, and prosthetic loosening are all potential complications. Deep venous thromboses and pulmonary emboli are concerns, however little is known regarding which patients should receive prophylaxis, the length of prophylactic therapy, and the age at which there is a concern for potential thrombosis. The most common reasons for reoperation are wound complications and infection. The soft tissues are usually compromised by poor vascularity. Radiation and chemotherapy also have a significant impact on wound healing. Debridement with further soft tissue coverage may be needed. Failure of allograft fixation, prosthetic loosening, and limb-length inequality are also potential complications needing further surgical intervention. Local recurrence may occur and this will need to be addressed with repeat wide resection or amputation depending on neurovascular involvement and anatomic location. The rehabilitation is often extensive after limb preservation....

  • Open Access

    Pathological fractures of the proximal humerus treated with a proximal humeral locking plate and bone cement

    by H. J. Siegel, R. Lopez-Ben, J. P. Mann, B. A. Ponce

    Bone loss secondary to primary or metastatic lesions of the proximal humerus remains a challenging surgical problem. Options include preservation of the joint with stabilisation using internal fixation or resection of the tumour with prosthetic replacement. Resection of the proximal humerus often includes the greater tuberosity and adjacent diaphysis, which may result in poor function secondary to loss of the rotator cuff and/or deltoid function. Preservation of the joint with internal fixation may reduce the time in hospital and peri-operative morbidity compared with joint replacement, and result in a better functional outcome. We included 32 patients with pathological fractures of the proximal humerus in this study. Functional and radiological assessments were performed. At a mean follow-up of 17.6 months (8 to 61) there was no radiological evidence of failure of fixation. The mean revised musculoskeletal Tumour Society functional score was 94.6% (86% to 99%). There was recurrent tumour requiring further surgery in four patients (12.5%). Of the 22 patients who were employed prior to presentation all returned to work without restrictions. The use of a locking plate combined with augmentation with cement extends the indications for salvage of the proximal humerus with good function in patients with pathological and impending pathological fractures.


    • 1 January 2009
      • Vol. 18  (2) , 93-8

    Unplanned surgical excision of extremity soft tissue sarcomas: patient profile and referral patterns.

    by Herrick J Siegel, Ouida Brown, Robert Lopez-Ben, Gene P Siegal

    Unplanned surgical excision of sarcomas remains a major treatment dilemma in the control of local disease. The purpose of this study is to develop a patient profile to identify patients at high risk for an unplanned excision. The study group consisted of 54 patients following an unplanned excision of a soft tissue sarcoma. The characteristics that were identified as high risk included the following: 20- to 40-year age range,>5 cm, trauma, and deep to fascia. It was common for the interpretation of imaging studies not to mention the possibility of sarcoma in the differential diagnosis. Patient referral was most commonly from general surgeons without specialty training in oncology. Orthopaedic surgeons should not rely solely on the radiologist's interpretation because they often lack clinical information necessary to direct them toward the diagnosis of sarcoma. This is particularly important in patients who are at high risk for unplanned excision as identified in this study. Unplanned excisions by nononcologic surgeons remain a problem; however, it appears that it is more prevalent in the general surgical community than in orthopaedics. This may be as a result of studies addressing this issue in orthopaedic journals, with emphasis of these articles at teaching institutions.


    • 1 August 2008
      • Vol. 37  (8) , E141-3

    Giant eccrine spiradenoma of the hand.

    by Herrick J Siegel, Nasser Said-Al-Naief, James Long, Robert R Lopez-Ben, Michael Klein


  • Current concepts on the surgical and medical management of osteosarcoma

    by Herrick J Siegel, Joseph G Pressey

    Although advances have been made in both surgical and medical management of patients with osteosarcoma, the overall survival of patients with osteosarcoma has remained constant, with no substantial improvement in the past 15 years. Advances in imaging have had a substantial impact on surgical planning and staging. These advances have, in turn, had a major impact on the surgeon's ability to perform limb-sparing surgery. Surgical techniques have improved in terms of instrumentation, modularity of implants and availability. Limb salvage has proven to be an acceptable method of treatment both with respect to oncologic and functional outcome in those patients where a wide resection may be achieved. The use of massive allografts has been largely replaced with the use of modern oncologic endoprostheses. Biologic targets that will enable new therapies to have maximum effect on tumor cells while minimizing toxicity to the host tissues need to be identified.


  • Vacuum‐assisted closure for radiation‐associated wound complications

    by Herrick J. Siegel, James L. Long, Kevin M. Watson, John B. Fiveash

    Background and Objectives: Vacuum‐assisted closure (VAC) technology has proven to be effective in the management of soft tissue loss from infections, vascular insufficiency, and traumatic disorders and may have a similar benefit in the musculoskeletal oncology patient. This study reports a single institution's experience with VAC technology in the management of radiation‐associated wound complications in patients with soft tissue sarcomas.Materials: Twenty‐two patients treated with both surgical intervention and radiation therapy developed either superficial or deep wound complications that were managed with the VAC device. This study group was compared to a retrospectively identified comparison group of 19 patients, in which the VAC device was not used.Results: Hospital stay (P < 0.025), length of overall treatment (P < 0.025), number of operative debridements (P < 0.05) and success of wound closure without the need for soft tissue transposition (P < 0.01) was found to be significantly less in the study groups as compared to those not treated with the VAC device.Conclusion: VAC technology appears to be safe and effective in the treatment of radiation‐associated wound complications. J. Surg. Oncol. 2007;96:575–582.


  • An 18-year-old Man with Knee Pain

    by Herrick J Siegel, Robert Lopez-Ben, Nasser Said-Al-Naief, Gene P Siegal